oxazepam has been researched along with Depression in 33 studies
Oxazepam: A benzodiazepine used in the treatment of anxiety, alcohol withdrawal, and insomnia.
oxazepam : A 1,4-benzodiazepinone that is 1,3-dihydro-2H-1,4-benzodiazepin-2-one substituted by a chloro group at position 7, a hydroxy group at position 3 and phenyl group at position 5.
Depression: Depressive states usually of moderate intensity in contrast with MAJOR DEPRESSIVE DISORDER present in neurotic and psychotic disorders.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Patients were encouraged to regulate their own dosage of oxazepam, and no difficulties occurred with this technique." | 5.26 | Oxazepam in the treatment of anxiety associated with depression: results of treatment in 1600 cases (Studies in depression, VI). ( Bailey, HR; Davies, E; Morrison, IJ, 1981) |
| "Forty-eight patients with anxiety states were treated with oxazepam (Serenid-D), which was administered in tablets of three different colours-red, yellow, and green." | 5.03 | Study on the effects of tablet colour in the treatment of anxiety states. ( Griffiths, NR; McClelland, HA; Newell, DJ; Schapira, K, 1970) |
| "A patient developed severe anxiety, moodswing, depression, and thinking disorder 24 hours after abruptly stopping oxazepam, of which he had taken 30 mg 3 times a day for two months, for anxiety and panic attacks." | 3.66 | Abstinence syndrome from therapeutic doses of oxazepam. ( Kulik, AV; Wilbur, R, 1983) |
| "The progression in severity of withdrawal symptoms (increase in CIWA-Ar above baseline) was also significantly greater in the placebo group (p < 0." | 2.70 | Divalproex sodium in alcohol withdrawal: a randomized double-blind placebo-controlled clinical trial. ( Baer, JS; Malte, CA; Reoux, JP; Saxon, AJ; Sloan, KL, 2001) |
| " Recent research suggests that this is due to metabolic and pharmacokinetic differences rather than an intrinsically more favourable toxic-to-therapeutic dosage ratio." | 2.64 | The clinical activity of oxazepam. ( Cardon, A; Fouks, L; Pinalie, B; Porcheron, JB, 1978) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 28 (84.85) | 18.7374 |
| 1990's | 1 (3.03) | 18.2507 |
| 2000's | 2 (6.06) | 29.6817 |
| 2010's | 2 (6.06) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tvete, IF | 1 |
| Bjørner, T | 1 |
| Skomedal, T | 1 |
| Howland, RH | 1 |
| SCASSERRA, BB | 1 |
| Cotroneo, A | 1 |
| Gareri, P | 1 |
| Nicoletti, N | 1 |
| Lacava, R | 1 |
| Grassone, D | 1 |
| Maina, E | 1 |
| De Sarro, G | 1 |
| Cabodi, S | 1 |
| Wilbur, R | 1 |
| Kulik, AV | 1 |
| Bailey, HR | 2 |
| Davies, E | 1 |
| Morrison, IJ | 1 |
| Bieganowski, L | 1 |
| Czerwiński, M | 1 |
| Reoux, JP | 1 |
| Saxon, AJ | 1 |
| Malte, CA | 1 |
| Baer, JS | 1 |
| Sloan, KL | 1 |
| Yesavage, J | 1 |
| Azcarate, CL | 1 |
| Gmür, M | 1 |
| Angst, J | 1 |
| Fouks, L | 1 |
| Pinalie, B | 1 |
| Porcheron, JB | 1 |
| Cardon, A | 1 |
| Vinar, O | 1 |
| Dostalová, J | 1 |
| Krsiak, M | 1 |
| Reznícek, V | 1 |
| Ivanys, E | 1 |
| Laffranchini, S | 1 |
| Rimón, R | 1 |
| Kultalahti, ER | 1 |
| Kalli, A | 1 |
| Koskinen, T | 1 |
| Lepola, U | 1 |
| Naarala, M | 1 |
| Tick, E | 1 |
| Väisänen, E | 1 |
| Jalkanen, E | 1 |
| Hollister, LE | 1 |
| Prokudin, VN | 1 |
| Edelstein, EL | 1 |
| Isac, M | 1 |
| Stein, J | 1 |
| Ladame, FG | 1 |
| Blackwell, B | 1 |
| Bobon, J | 1 |
| Collard, J | 1 |
| Breulet, M | 1 |
| Claghorn, J | 1 |
| Kellner, R | 1 |
| Hanna, SM | 1 |
| Harry, TV | 1 |
| Adler, F | 1 |
| Reiner, M | 1 |
| Schapira, K | 1 |
| McClelland, HA | 1 |
| Griffiths, NR | 1 |
| Newell, DJ | 1 |
| Maccagnani, G | 1 |
| Ferri, G | 1 |
| Albonetti, G | 1 |
| Malm, U | 1 |
| Thomas, JC | 1 |
| Selig, JW | 1 |
| Guthy, H | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Placebo Controlled Trial of Depakote ER in Alcohol Dependent Patients With Mood and/or Anxiety Symptoms[NCT00202514] | Phase 2/Phase 3 | 40 participants | Interventional | 2004-09-30 | Completed | ||
| Prospective Assessment of Valproate on Ethanol Withdrawal[NCT03235531] | Phase 4 | 210 participants (Anticipated) | Interventional | 2017-07-11 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for oxazepam and Depression
| Article | Year |
|---|---|
Minor tranquilizers in the treatment of aggression.
Topics: Aggression; Animals; Anti-Anxiety Agents; Anxiety; Chlordiazepoxide; Depression; Diazepam; Epilepsy; | 1975 |
[Features of the clinical effect of benzodiazepine derivatives (according to the findings of comparative studies). Review of the literature].
Topics: Adjustment Disorders; Aggression; Animals; Antisocial Personality Disorder; Barbiturates; Benzazepin | 1973 |
13 trials available for oxazepam and Depression
| Article | Year |
|---|---|
Divalproex sodium in alcohol withdrawal: a randomized double-blind placebo-controlled clinical trial.
Topics: Adolescent; Adult; Aged; Alcoholism; Anticonvulsants; Anxiety; Depression; Double-Blind Method; Etha | 2001 |
Divalproex sodium in alcohol withdrawal: a randomized double-blind placebo-controlled clinical trial.
Topics: Adolescent; Adult; Aged; Alcoholism; Anticonvulsants; Anxiety; Depression; Double-Blind Method; Etha | 2001 |
Divalproex sodium in alcohol withdrawal: a randomized double-blind placebo-controlled clinical trial.
Topics: Adolescent; Adult; Aged; Alcoholism; Anticonvulsants; Anxiety; Depression; Double-Blind Method; Etha | 2001 |
Divalproex sodium in alcohol withdrawal: a randomized double-blind placebo-controlled clinical trial.
Topics: Adolescent; Adult; Aged; Alcoholism; Anticonvulsants; Anxiety; Depression; Double-Blind Method; Etha | 2001 |
[Combination of phenylpyrrolidinopentane (Katovit) and oxazepam (Adumbran). A double-blind comparison with opipramol (Insidon) in depressive syndromes].
Topics: Adult; Clinical Trials as Topic; Depression; Double-Blind Method; Drug Therapy, Combination; Female; | 1977 |
The clinical activity of oxazepam.
Topics: Alcoholism; Anxiety Disorders; Clinical Trials as Topic; Depression; Drug Evaluation; Humans; Mental | 1978 |
Controlled comparison of the therapeutic effects of natrium oxybutyrate and oxazepam.
Topics: Adolescent; Adult; Aged; Anxiety; Depersonalization; Depression; Double-Blind Method; Humans; Hydrox | 1979 |
[5 years' experience with a new tranquilizer lexotanil (ro 5-3350) in ambulatory patients in a psychiatric practice (author's transl)].
Topics: Anxiety; Benzodiazepines; Chemical Phenomena; Chemistry; Clinical Trials as Topic; Depression; Drug | 1975 |
Alprazolam and oxazepam in the treatment of anxious out-patients with depressive symptoms: a double-blind multicenter study.
Topics: Adult; Alprazolam; Anxiety Disorders; Depression; Double-Blind Method; Humans; Middle Aged; Oxazepam | 1991 |
A double-blind study of alprazolam and oxazepam in the treatment of anxiety.
Topics: Adult; Alprazolam; Anxiety Disorders; Depression; Double-Blind Method; Female; Humans; Male; Middle | 1987 |
[Prudent use of drugs against anxiety].
Topics: Anxiety; Chemical Phenomena; Chemistry; Depression; Diazepam; Evaluation Studies as Topic; Humans; H | 1973 |
How antagonistic can doctor's bias be on drug effect? Oxazepam as an anti-anxiety agent.
Topics: Anxiety; Anxiety Disorders; Attitude of Health Personnel; Clinical Trials as Topic; Countertransfere | 1973 |
[A comparative ambulatory experiment with Ro 5-3350 (Lexotanil) and oxazepam (author's transl)].
Topics: Adolescent; Adult; Aged; Anxiety; Benzodiazepinones; Clinical Trials as Topic; Depression; Drug Eval | 1974 |
When is a tranquillizer an antidepressant?
Topics: Adult; Antidepressive Agents; Anxiety Disorders; Clinical Trials as Topic; Depression; Dibenzocycloh | 1971 |
[Evaluation of a new tranquilizer, Seresta, in a medical policlinic].
Topics: Aged; Antidepressive Agents; Anxiety Disorders; Clinical Trials as Topic; Depression; Female; Humans | 1966 |
Study on the effects of tablet colour in the treatment of anxiety states.
Topics: Adult; Analysis of Variance; Anxiety; Color; Depression; Female; Humans; Male; Oxazepam; Phobic Diso | 1970 |
18 other studies available for oxazepam and Depression
| Article | Year |
|---|---|
A 5-year follow-up study of users of benzodiazepine: starting with diazepam versus oxazepam.
Topics: Adult; Anti-Anxiety Agents; Anxiety; Depression; Diazepam; Dose-Response Relationship, Drug; Drug Pr | 2016 |
Oxazepam for the Treatment of Substance Abuse and Depression: Is it Appropriate?
Topics: Depression; Humans; Hypnotics and Sedatives; Oxazepam; Substance-Related Disorders | 2016 |
PLACE OF AN ANTI-ANXIETY AGENT IN GENERAL PRACTICE.
Topics: Adolescent; Anti-Anxiety Agents; Antidepressive Agents; Anxiety; Anxiety Disorders; Child; Depressio | 1965 |
Effectiveness and safety of hypnotic drugs in the treatment of insomnia in over 70-year old people.
Topics: Aged; Cognition Disorders; Dementia; Depression; Drug Administration Schedule; Female; Health Status | 2007 |
Abstinence syndrome from therapeutic doses of oxazepam.
Topics: Adult; Anxiety; Depression; Depressive Disorder; Diazepam; Fasciculation; Fear; Humans; Male; Oxazep | 1983 |
Oxazepam in the treatment of anxiety associated with depression: results of treatment in 1600 cases (Studies in depression, VI).
Topics: Adult; Anxiety; Depression; Drug Therapy, Combination; Female; Humans; Male; Oxazepam | 1981 |
[Decompensation of glaucoma after administration of tricyclic antidepressants and anxiolytic drugs].
Topics: Amitriptyline; Depression; Female; Glaucoma; Humans; Imipramine; Intraocular Pressure; Middle Aged; | 1980 |
Dementia: differential diagnosis and treatment.
Topics: Antidepressive Agents, Tricyclic; Dementia; Depression; Diagnosis, Differential; Dihydroergotoxine; | 1979 |
Studies in depression. II. Treatment of the depressed, frigid woman.
Topics: Adult; Clitoris; Depression; Estradiol; Female; Humans; Oxazepam; Psychotherapy; Sex Education; Sexu | 1973 |
Psychotropic drugs in use today. The role of diazepam in medical practice.
Topics: Anxiety Disorders; Chlordiazepoxide; Depression; Diazepam; Drug Interactions; Drug Utilization; Fami | 1973 |
[Oxazepam or WY 3498, a new muscle-relaxing tranquilizer in ambulatory treatment].
Topics: Antidepressive Agents; Anxiety Disorders; Depression; Female; Gastrointestinal Diseases; Humans; Mal | 1965 |
A case of oxazepam (serenid D) dependence.
Topics: Adult; Anxiety; Depression; Humans; Male; Oxazepam; Phenelzine; Substance Withdrawal Syndrome; Subst | 1972 |
Oxazepam (Serenid D) dependence.
Topics: Adult; Depression; Humans; Male; Oxazepam; Substance Withdrawal Syndrome; Substance-Related Disorder | 1972 |
[Preliminary therapeutic results with a new derivative of benzodiazepine: Oxazepam (Rav. 3031)].
Topics: Adolescent; Adult; Aged; Anxiety; Child; Depression; Female; Humans; Male; Mental Disorders; Middle | 1967 |
[Oxazepam in alcoholism, depression and anxiety neuroses. A preliminary trial].
Topics: Absenteeism; Adolescent; Adult; Aged; Alcoholism; Anxiety Disorders; Depression; Humans; Male; Middl | 1968 |
Clinical evaluation of oxazepam in an out-patient psychiatric clinic.
Topics: Adult; Antidepressive Agents; Anxiety; Depression; Female; Humans; Male; Outpatient Clinics, Hospita | 1966 |
A possible oxazepam abstinence syndrome.
Topics: Adult; Antidepressive Agents; Depression; Female; Humans; Oxazepam; Psychotic Disorders; Substance W | 1966 |
[Experiences with adumbran in a neurologic practice].
Topics: Depression; Dysautonomia, Familial; Humans; Mental Disorders; Neurotic Disorders; Oxazepam | 1966 |